Estradiol benzoate/testosterone isobutyrate: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
Line 27: Line 27:
{{stub}}
{{stub}}
{{No image}}
{{No image}}
<gallery>
File:Estradiol_benzoate.svg|Estradiol benzoate
File:Testosterone_isobutyrate.svg|Testosterone isobutyrate
</gallery>

Revision as of 21:34, 20 February 2025

Testosterone Isobutyrate (also known as Agovirin-Depot and Perandren M) is an androgen and anabolic steroid medication. It is a testosterone ester used for treating conditions such as low testosterone levels in men and delayed puberty in boys. This medication is currently available only in the Czech Republic.

Etymology

The term "Testosterone Isobutyrate" is derived from its chemical structure. "Testosterone" is the primary male sex hormone, "iso" refers to the isomer structure, and "butyrate" refers to the butyric acid ester.

Medical Uses

Testosterone Isobutyrate is used in the treatment of conditions related to low testosterone levels in men. These conditions may include hypogonadism, a condition where the body does not produce enough testosterone. It is also used in the treatment of delayed puberty in boys.

Pharmacology

As an androgen and anabolic steroid, Testosterone Isobutyrate works by supplementing or replacing the testosterone that is naturally produced in the body. Testosterone is a hormone that is necessary for normal growth and development of male sex organs and for the maintenance of secondary sex characteristics.

Side Effects

Like all medications, Testosterone Isobutyrate can cause side effects. These may include acne, hair loss, and an increase in body hair. More serious side effects can include liver damage, heart disease, and mental health problems such as aggression and depression.

Availability

Testosterone Isobutyrate is currently available only in the Czech Republic, where it is sold under the brand names Agovirin-Depot and Perandren M.

See Also

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia